Ablation System News Today

A B.C. medical device company specializing in helping out heartbeats is keeping capital flowing through its corporate system.

Vancouver, B.C., medical device company has developed Globe Mapping and Ablation System

Medtronic's SPHERE Per-AF study results reveal the Sphere-9 Catheter's superior safety and efficacy in treating persistent atrial fibrillation compared to the Thermocool SmartTouch SF. The Sphere-9 offers advanced mapping and ablation, showing higher freedom from AFib and fewer complications.

AtriCure, Inc. , a leading innovator in surgical treatments and therapies for atrial fibrillation , left atrial appendage management, and post-operative pain management, today announced that it has...

/PRNewswire/ -- With the increase in life expectancy, people need more medical help and care. AI-enabled technologies can help people to live healthier and...

NovoCure (NASDAQ:NVCR – Get Free Report) and Minerva Surgical (NASDAQ:UTRS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends. Institutional and Insider Ownership 84.6% of NovoCure shares […]

Profound Medical (NASDAQ:PROF – Get Free Report) and Minerva Surgical (NASDAQ:UTRS – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk. Volatility and Risk Profound Medical has a […]

Profound Medical (NASDAQ:PROF – Get Free Report) and Minerva Surgical (NASDAQ:UTRS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk and valuation. Volatility & Risk Profound Medical has a […]

/PRNewswire/ -- On March 28, 2024, Broncus Medical (02216.HK) (the "Company" or "we" ) announced annual results for FY 2023. In 2023, Broncus Medical earned...

AtriCure, Inc. , a leading innovator in surgical treatments and therapies for atrial fibrillation , left atrial appendage management, and post-operative pain management, today announced that the...